WHAT IS THE MODE OF ACTION OF THIOCYANATE COMPOUNDS IN ESSENTIAL HYPERTENSION?
Authors: C B THOMAS
Journal: Annals of Internal Medicine (1952)

Article1 July 1952WHAT IS THE MODE OF ACTION OF THIOCYANATE COMPOUNDS IN ESSENTIAL HYPERTENSION?CAROLINE BEDELL THOMAS, M.D., F.A.C.P.CAROLINE BEDELL THOMAS, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-37-1-106 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptINTRODUCTIONAlthough the thiocyanate compounds have been used as remedies for essential hypertension since early in the Twentieth Century, our incomplete knowledge of their mode of action, and the variability of the clinical response, have served to throw doubt upon their therapeutic value. Evidence is accumulating, however, that the thiocyanate ion may have a specific action upon some of the glands of internal secretion, including the adrenal cortex. In view of the recent interest concerning the rôle of the adrenal cortex in the pathogenesis of essential hypertension,1-7it seems worth while to review what is already known, to present some...Bibliography1. Perera GA: The relationship of the adrenal cortex to hypertension. Observations on the effect of hypoadrenalism in a patient with hypertensive vascular disease, J. A. M. A. 129: 537, 1945. CrossrefGoogle Scholar2. Selye H: The general adaptation syndrome and the diseases of adaptation, J. Clin. Endocrinol. 6: 117, 1946. CrossrefGoogle Scholar3. GreenNelsonDodds DMJNGA: Effects of adrenal resection on hypertension and diabetes, Federation Proc. 8: 60, 1949. Google Scholar4. LukensWolferthJeffersZintelHafkenschiel FDCCWAHAJH: Observations on subtotal adrenalectomy in hypertension, Tr. Am. Clin. and Climatol. A. 62: 229, 1950. MedlineGoogle Scholar5. GreenNelsonDoddsSmalley DMJNGARE: Bilateral adrenalectomy in malignant hypertension and diabetes, J. A. M. A. 144: 439, 1950. CrossrefMedlineGoogle Scholar6. ZintelWolferthJeffersHafkenschielLukens HACCWAJHFD: Ninety-five per cent subtotal adrenalectomy for essential hypertension, Am. College Surg. "Surgical Forum," 1951, W. B. Saunders Co., Philadelphia. Google Scholar7. WolferthJeffersLukensZintelHafkenschiel CCWAFDHAJH: Observations on the results of subtotal adrenalectomy in the treatment of severe, otherwise intractable, hypertension and their bearing on the mechanism by which hypertension is maintained, Ann. Int. Med. 35: 8, 1951. LinkGoogle Scholar8. Bernard C: Leçons sur les effets des substances toxiques et médicamenteuses, 1857, Bailliere, Paris, pp. 354-385. CrossrefGoogle Scholar9. Pauli W: Ueber Ionenwirkungen und ihre therapeutische Verwendung, München. med. Wchnschr. 50: 153, 1903. Google Scholar10. Nichols JB: The pharmacologic and therapeutic properties of the sulphocyanates, Am. J. M. Sc. 170: 735, 1925. CrossrefGoogle Scholar11. SmithRudolf AGRD: The use of sulphocyanate of soda in high blood pressure, Canad. M. A. J. 19: 288, 1928. MedlineGoogle Scholar12. Barker MH: The blood cyanates in the treatment of hypertension, J. A. M. A. 106: 762, 1936. CrossrefGoogle Scholar13. BarkerLindbergWald MHHAMH: Further experiences with thiocyanates. Clinical and experimental observations, J. A. M. A. 117: 1591, 1941. CrossrefGoogle Scholar14. DavisBarker LMH: Clinical and experimental experiences in the surgical treatment of hypertension, Ann. Surg. 110: 1016, 1939. CrossrefMedlineGoogle Scholar15. HarrisonWintrobeBeesonResnikThorn TRMMPBWHGW: Principles of internal medicine, 1951, The Blakiston Company, Philadelphia. CrossrefGoogle Scholar16. Mulinos MG: Pharmacology, 1951, Oxford University Press, New York. Google Scholar17. KrugMcGuigan EEHA: An introduction to materia medica and pharmacology, 5th ed., 1948, C. V. Mosby Co., St. Louis. Google Scholar18. WaldLindbergBarker MHHAMH: The toxic manifestations of the thiocyanates, J. A. M. A. 112: 1120, 1939. CrossrefGoogle Scholar19. RichardsBrockhurstColeman CERJTH: Thiocyanate goiter with myxedema. Report of two cases, J. Clin. Endocrinol. 9: 446, 1949. CrossrefGoogle Scholar20. Astwood EB: The chemical nature of compounds which inhibit the function of the thyroid gland, J. Pharmacol. and Exper. Therap. 78: 79, 1943. Google Scholar21. WilliamsJaffeTaylor RHHJA: Effect of halides, thiocyanate and propylthiouracil upon the distribution of radioiodine in the thyroid gland, blood and urine, Am. J. M. Sc. 219: 7, 1950. CrossrefMedlineGoogle Scholar22. WoodWilliams JLEF: The metabolism of thiocyanate in the rat and its inhibition by propylthiouracil, J. Biol. Chem. 177: 59, 1949. CrossrefMedlineGoogle Scholar23. Healy JC: Therapeutics and toxicology of the sulphocyanates, New England J. Med. 205: 581, 1931. CrossrefGoogle Scholar24. CorcoranTaylorPage ACRDIH: Renal function in hypertensive patients during treatment with thiocyanate, Proc. Am. Federation Clin. Research 2: 11, 1945. MedlineGoogle Scholar25. DavisTanturiTarkington LCAJA: The combination of sympathectomy and thiocyanates in the treatment of experimental and essential, or high diastolic, hypertension, Tr. Am. S. A. 68: 74, 1950. Google Scholar26. DavisTarkingtonAnderson LJRK: Physiologic principles underlying the treatment of high diastolic hypertension by thiocyanates and sympathectomy, Ann. Surg. 133: 867 (June) 1951. CrossrefMedlineGoogle Scholar27. FischmannFischman EJA: Thiocyanate in hypertension. Blood pressure behavior after withdrawal of the drug, and serial electrocardiograms as criteria of response, Am. Heart J. 39: 477, 1950. MedlineGoogle Scholar28. WatkinsonEvans GG: Potassium thiocyanate in the treatment of hypertension, Brit. M. J. 1: 595, 1947. CrossrefMedlineGoogle Scholar29. Alstad KS: Effect of thiocyanate on basal blood pressure, Brit. M. J. 1: 250, 1948. CrossrefMedlineGoogle Scholar30. Alstad KS: The effects of thiocyanate on basal and supplemental blood pressures, Brit. Heart J. 11: 249, 1949. CrossrefMedlineGoogle Scholar31. BlumenthalWetherby JSM: Potassium thiocyanate in hypertension, Minnesota Med. 27: 177, 1944. Google Scholar32. GoldringChasis WH: Hypertension and hypertensive disease, 1944, The Commonwealth Fund, New York. Google Scholar33. KesslerHines DLLE: Hazards of thiocyanate therapy in hypertension, J. A. M. A. 138: 549, 1948. CrossrefMedlineGoogle Scholar34. Barker MH: The use of cyanates in the treatment of hypertension, Wisconsin M. J. 36: 28, 1937. Google Scholar35. CecilLoeb RLRF: A textbook of medicine, 8th ed., 1951, W. B. Saunders Co., Philadelphia. Google Scholar36. ThomasBrooks CBCM: The effect of sympathectomy on the vasomotor carotid sinus reflexes of the cat, Am. J. Physiol. 120: 195, 1937. CrossrefGoogle Scholar37. ThomasWarthin CBTA: The response of normal dogs and dogs with experimental hypertension to a standard cold stimulus, Am. Heart J. 19: 316, 1940. CrossrefGoogle Scholar38. Thomas CB: Experimental hypertension from section of moderator nerves: relationship to presence of kidney tissue, Proc. Soc. Exper. Biol. and Med. 48: 24, 1941. CrossrefGoogle Scholar39. WarthinThomas TACB: Studies in experimental hypertension. I. Phenol red excretion and renal blood flow in hypertension of renal origin, Bull. Johns Hopkins Hosp. 72: 203, 1943. Google Scholar40. AlpertThomas LKCB: Studies in experimental hypertension. II. The effect of dietary protein on the urea clearance and arterial blood pressure in chronic hypertension, Bull. Johns Hopkins Hosp. 72: 274, 1943. Google Scholar41. BlackmanThomasHoward SSCBJE: The effect of testosterone propionate on the arterial blood pressure, kidneys, urinary bladder and livers of growing dogs, Bull. Johns Hopkins Hosp. 74: 321, 1944. Google Scholar42. Thomas CB: Experimental hypertension from section of moderator nerves: relationship of the acute pressor response to the development and course of chronic hypertension, Bull. Johns Hopkins Hosp. 74: 335, 1944. Google Scholar43. ThomasMcLean CBRL: The effect of intravenous injection of epinephrin and angiotonin before and after the production of neurogenic hypertension, Bull. Johns Hopkins Hosp. 75: 319, 1944. Google Scholar44. BingThomas RJCB: The effect of two dioxane derivatives, 883 and 933F, on normal dogs and on animals with neurogenic and renal hypertension, J. Pharmacol. and Exper. Therap. 83: 21, 1945. Google Scholar45. BingThomasWaples RJCBEC: The circulation in experimental neurogenic hypertension, J. Clin. Investigation 24: 513, 1945. CrossrefMedlineGoogle Scholar46. LyonsMoeNelighHooblerCampbellBerryRennich RHGKRBSWKNRLBR: The effects of blockade of the autonomic ganglia in man with tetraethyl ammonium. Preliminary observations on its clinical application, Am. J. M. Sc. 213: 315, 1947. CrossrefMedlineGoogle Scholar47. LevinsonReiserFerris JEMFEB: Variations in the blood pressure response to repeated administration of tetraethyl ammonium chloride, J. Clin. Investigation 27: 154, 1948. CrossrefGoogle Scholar48. ReiserFerris MFEB: The nature of the cold pressor test and its significance in relation to neurogenic and humoral mechanisms in hypertension, J. Clin. Investigation 27: 156, 1948. CrossrefMedlineGoogle Scholar49. Schroeder HA: Arterial hypertension, Veterans Administration Technical Bulletin TB 10-59, p. 1, Nov. 30, 1949. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Baltimore, Maryland*Received for publication February 11, 1952.From the Department of Medicine, The Johns Hopkins University School of Medicine and Hospital, Baltimore. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHypertonieHypertonieTHIRTY-THREE YEARS’ EXPERIENCE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION†HypertonieThe Treatment of HypertensionObservations on thyroid function in hypertensive patients treated with potassium thiocyanateThe Medical Management of Arterial Hypertension 1 July 1952Volume 37, Issue 1Page: 106-122KeywordsAdrenal cortexHospital medicineHypertensionPathogenesis Issue Published: 1 July 1952 PDF downloadLoading ...